P
US9353153B2ActiveUtilityPatentIndex 80

Cyclic RNA and protein production method

Assignee: RIKENPriority: Feb 9, 2012Filed: Feb 8, 2013Granted: May 31, 2016
Est. expiryFeb 9, 2032(~5.6 yrs left)· nominal 20-yr term from priority
Inventors:ABE HIROSHIABE NAOKOITO YOSHIHIRONISHIHARA MIZUKI
C12P 21/02C12N 15/66C07K 7/06C12P 21/00C12N 15/10
80
PatentIndex Score
10
Cited by
10
References
15
Claims

Abstract

The present invention provides a cyclic RNA preferable for carrying out rotary protein translation in which translation domains other than that of the target protein are sufficiently short and translation efficiency is high, and a method for producing protein that uses this cyclic RNA as template. More specifically, the present invention provides a cyclic RNA that encodes a protein, has a full-length number of bases that is equal to or greater than 102 and is a multiple of 3, has at least one start codon, does not have a stop codon in the same reading frame as the start codon, and does not contain an internal ribosome entry site (IRES). In addition, the present invention provides a method for producing protein in a eukaryotic cell expression system that consists of using the aforementioned cyclic RNA as template and expressing a protein encoded by that cyclic RNA.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method for producing protein in eukaryotic cells or in a eukaryotic cell expression system, comprising:
 introducing a cyclic RNA into eukaryotic cells, or adding the cyclic RNA to a eukaryotic cell-free expression system; and 
 expressing a protein encoded by the cyclic RNA using the cyclic RNA in the eukaryotic cells or eukaryotic cell-free expression system, 
 wherein the cyclic RNA encodes a protein, has a full-length number of bases that is equal to or greater than 102, and is a multiple of 3, has at least one start codon, does not have a stop codon in the same reading frame as the start codon, and does not contain an internal ribosome entry site (IRES). 
 
     
     
       2. The method for producing protein according to  claim 1 , wherein the eukaryotic cells are mammalian cells, and the eukaryotic cell-free expression system is a mammalian cell-free expression system. 
     
     
       3. A method for producing protein in a prokaryotic cell or in a prokaryotic cell expression system, comprising:
 introducing a cyclic RNA into prokaryotic cells, or adding the cyclic RNA to a prokaryotic cell-free expression system; and 
 expressing a protein encoded by the cyclic RNA using the cyclic RNA in the prokaryotic cells or the prokaryotic cell-free expression system, 
 wherein the cyclic RNA encodes a protein, has a full-length number of bases that is from 102 to 561 and is a multiple of 3, has at least one ribosome binding site recognized by ribosomes derived from prokaryotic cells, has a plurality of start codons, with only one of the plurality of start codons within 1 to 20 bases downstream from the ribosome binding site, and does not have a stop codon in the same reading frame as the start codon. 
 
     
     
       4. The method according to  claim 3 , wherein the cyclic RNA does not contain an internal ribosome entry site (IRES). 
     
     
       5. The method according to  claim 3 , wherein the cyclic RNA has an Shine-Dalgarno (SD) sequence as the ribosome binding site. 
     
     
       6. The method according to  claim 3 , wherein the cyclic RNA has an open reading frame comprising the start codon within 1 to 20 bases downstream from the ribosome binding site, and has no other reading frame which comprises a start codon. 
     
     
       7. The method according to  claim 3 , wherein the cyclic RNA comprises a stop codon in a different reading frame from the start codon. 
     
     
       8. The method according to  claim 3 , wherein the protein comprises long chain repeated regions of peptide sequences defined by the cyclic RNA. 
     
     
       9. The method according to  claim 3 , wherein the cyclic RNA comprises a domain encoding a protease cleavage site. 
     
     
       10. The method according to  claim 1 , wherein the cyclic RNA has a Kozak sequence upstream from the start codon. 
     
     
       11. The method according to  claim 1 , wherein the cyclic RNA has an open reading frame comprising the start codon, and has no other reading frame which comprises a start codon. 
     
     
       12. The method according to  claim 1 , wherein the cyclic RNA comprises a stop codon in a different reading frame from the start codon. 
     
     
       13. The method according to  claim 1 , wherein the protein comprises long chain repeated regions of peptide sequences defined by the cyclic RNA. 
     
     
       14. The method according to  claim 1 , wherein the cyclic RNA comprises a domain encoding a protease cleavage site. 
     
     
       15. The method according to  claim 1 , wherein the cyclic RNA comprises a full-length number of bases that is less than or equal to 561 bases.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.